Xiyi Lu
Impact in
- Cancer Research top 2%
- Cancer-related molecular mechanisms research
- MicroRNA in disease regulation
- General Dentistry top 5%
Papers in
-
- Cancer-related molecular mechanisms research 12
-
- RNA modifications and cancer 8
- RNA Research and Splicing 4
- Circular RNAs in diseases 3
- Co-authors
- Erbao Zhang (13 shared papers)Xuezhi He (11 shared papers)Liang Han (7 shared papers)Dandan Yin (7 shared papers)Renhua Guo (7 shared papers)Jun Su (4 shared papers)Wei De (3 shared papers)Shidai Jin (4 shared papers)
- Journals
- Molecular Therapy — Nucleic Acids (4 papers)Advanced Materials (2 papers)Cellular Physiology and Biochemistry (2 papers)Oncogene (2 papers)Oncotarget (2 papers)
- Partner nations
- ChinaUnited StatesFinland
In The Last Decade
Xiyi Lu
27 papers receiving 1.0k citations
Xiyi Lu's Hit Papers
Peers
Comparison fields: 5 of 74
- Cancer Research 629
- General Dentistry 29
- Molecular Biology 642
- Obstetrics and Gynecology 25
- Pathology and Forensic Medicine 54
Countries citing papers authored by Xiyi Lu
This map shows the geographic impact of Xiyi Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Xiyi Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Xiyi Lu more than expected).
Fields of papers citing papers by Xiyi Lu
This network shows the impact of papers produced by Xiyi Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Xiyi Lu. The network helps show where Xiyi Lu may publish in the future.
Co-authors
The 25 scholars most cited alongside Xiyi Lu, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2018 | 222 | |
| 2 | 2019 | 104 | |
| 3 | 2018 | 99 | |
| 4 | 2017 | 82 | |
| 5 | 2022 | 68 | |
| 6 | 2018 | 62 | |
| 7 | 2017 | 47 | |
| 8 | 2018 | 40 | |
| 9 | 2022 | 38 | |
| 10 | 2018 | 36 | |
| 11 | 2018 | 34 | |
| 12 | 2019 | 33 | |
| 13 | NNMT promotes acquired EGFR-TKI resistance by forming EGR1 and lactate-mediated double positive feedback loops in non-small cell lung cancer Hit paper breakdown → | 2025 | 31 |
| 14 | 2018 | 30 | |
| 15 | Cancer-associated fibroblasts promote EGFR-TKI resistance via the CTHRC1/glycolysis/H3K18la positive feedback loop Hit paper breakdown → | 2025 | 28 |
| 16 | A novel long noncoding RNA IRAIN regulates cell proliferation in non small cell lung cancer. | 2015 | 22 |
| 17 | 2024 | 17 | |
| 18 | 2023 | 14 | |
| 19 | 2024 | 10 | |
| 20 | 2017 | 9 |
About Xiyi Lu
Xiyi Lu is a scholar working on Cancer Research, Molecular Biology, Pulmonary and Respiratory Medicine, Oncology and Pathology and Forensic Medicine, having authored 28 papers that have together received 1.0k indexed citations. Recurring topics across this work include Cancer-related molecular mechanisms research (12 papers), RNA modifications and cancer (8 papers), RNA Research and Splicing (4 papers), Lung Cancer Treatments and Mutations (4 papers), Circular RNAs in diseases (3 papers), Spinal Cord Injury Research (2 papers), Traumatic Brain Injury and Neurovascular Disturbances (1 paper) and Dental Research and COVID-19 (1 paper). The work is most often cited by research in Cancer Research (629 citations), General Dentistry (29 citations), Molecular Biology (642 citations), Obstetrics and Gynecology (25 citations) and Pathology and Forensic Medicine (54 citations). Xiyi Lu has collaborated with scholars based in China, United States and Finland. Frequent co-authors include Erbao Zhang, Xuezhi He, Liang Han, Dandan Yin, Renhua Guo, Jun Su, Wei De, Shidai Jin, Wei Wang and Chongguo Zhang. Their work appears in journals such as Molecular Therapy — Nucleic Acids, Advanced Materials, Cellular Physiology and Biochemistry, Oncogene and Oncotarget.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.